Expect wide price swings. These fast growers with a lot of the bet on the future always have tremendous volatility and some investors can't handle it. I listened to the conference call and am impressed, especially by the compounds that are further along in testing. Do not get caught short when any of these hit the market. My holding here is backed by Regeneron, a smaller market cap and also great growth prospects.
Subscribers to Louis Navellier's BlueChipGrowth must be scratching their heads the last few days over his decision to 'cut and run' from REGN between $280 - $290 a few months back. Sure he made money for them with REGN but he might have made a lot more for them by hanging on a bit longer. (Of course there were subscribers who didn't follow the advice) ....... Waning 'buying pressure' ? Yeah, right !